When to evaluate effectiveness?- Anti-CGRPs and gepants

Session 1: New treatments – Evaluation and management

Erling Tronvik

MD, PhD - Scientific Director of NorHEAD, Senior Consultant at St.Olav University Hospital and Professor at Department of Neuromedicine and Movement Science, NTNU - Trondheim, Norway

Download presentation

Previous

Anti-CGRP therapies: similar but not the same

Next

When to switch? Anti-CGRPs and gepants